Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper-phosphorylating effects
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Mutations in the angiopoietin receptor TIE2/TEK have been identified as the cause for autosomal dominantly inherited cutaneomucosal venous malformation (VMCM). Thus far, two specific germline substitutions (R849W and Y897S), located in the kinase domain of TIE2, have been reported in five families. The mutations result in a fourfold increase in ligand-independent phosphorylation of the receptor. Here, we report 12 new families with TEK mutations. Although the phenotype is primarily characterized by small multifocal cutaneous vascular malformations, many affected members also have mucosal lesions. In addition, cardiac malformations are observed in some families. Six of the identified mutations are new, with three located in the tyrosine kinase domain, two in the kinase insert domain, and another in the carboxy terminal tail. The remaining six are R849W substitutions. Overexpression of the new mutants resulted in ligand-independent hyperphosphorylation of the receptor, suggesting this is a general feature of VMCM-causative TIE2 mutations. Moreover, variation in the level of activation demonstrates, to the best of our knowledge for the first time, that widely differing levels of chronic TIE2 hyperphosphorylation are tolerated in the heterozygous state, and are compatible with normal endothelial cell function except in the context of highly localized areas of lesion pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
Dumont, D. J., Gradwohl, G., Fong, G. H., Puri, M. C., Gertsenstein, M., Auerbach, A., & Breitman, M. L. (1994) · Genes & Development · doi:10.1101/gad.8.16.1897 · Cited by 985 · cited 1×
“Although cardiac septal defects are frequent in the general population, TIE2 mutations may have a predisposing effect and an important function in cardiac development, as indicated by the phenotypes of murine models with altered TIE2 signalling 14.”
Vascular Dysmorphogenesis Caused by an Activating Mutation in the Receptor Tyrosine Kinase TIE2
Vikkula, M., Boon, L. M., Iii, K. L. C., Calvert, J. T., Diamonti, A. J., Goumnerov, B., Pasyk, K. A., Marchuk, D. A., Warman, M. L., Cantley, L. C., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81814-0 · Cited by 802 · cited 4×
“A genetic approach led to the identification of a mutation in the endothelial-specific tyrosine kinase TIE2 in two families with VMCM 8.”
InfluentialSelf-citationLimaye, N., Wouters, V., Uebelhoer, M., Tuominen, M., Wirkkala, R., Mulliken, J. B., Eklund, L., Boon, L. M., & Vikkula, M. (2009) · Nature Genetics · doi:10.1038/ng.272 · Cited by 492
Self-citationBrouillard, P., Boon, L. M., Mulliken, J. B., Enjolras, O., Ghassibé, M., Warman, M. L., Tan, O. T., Olsen, B. R., & Vikkula, M. (2002) · The American Journal of Human Genetics · doi:10.1086/339492 · Cited by 342 · cited 2×
“Evidence for local mutations have also been reported in one patient with GVM, and patients with cerebral cavernous malformations: both dominant, multifocal, Mendelian disorders 4,22-24.”
Self-citationAkers, A. L., Johnson, E., Steinberg, G. K., Zabramski, J. M., & Marchuk, D. A. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddn430 · Cited by 292
Genetic causes of vascular malformations
Brouillard, P., & Vikkula, M. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm211 · Cited by 268 · cited 1×
“Venous malformation (VM) is the most frequent malformation referred to specialized vascular anomaly centers 1-3.”
Self-citationAssignment of a locus for dominantly inherited venous malformations to chromosome 9p
Boon, L. M., Mulliken, J. B., Vikkula, M., Watkins, H., Seidman, J., Olsen, B. R., & Warman, M. L. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.9.1583 · Cited by 216 · cited 1×
“We have hypothesized that a somatic second-hit on the wild-type allele could be required for a lesion to appear 19, following Knudson's double-hit mechanism20.”
Self-citationPagenstecher, A., Stahl, S., Sure, U., & Felbor, U. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddn420 · Cited by 210
A Gene for Inherited Cutaneous Venous Anomalies (“Glomangiomas”) Localizes to Chromosome 1p21-22
Boon, L. M., Brouillard, P., Irrthum, A., Karttunen, L., Warman, M. L., Rudolph, R., Mulliken, J. B., Olsen, B. R., & Vikkula, M. (1999) · The American Journal of Human Genetics · doi:10.1086/302450 · Cited by 176
Self-citationStructure of the Tie2 RTK Domain
Shewchuk, L. M., Hassell, A. M., Ellis, B., Holmes, W. D., Davis, R., Horne, E., Kadwell, S. H., McKee, D. D., & Moore, J. T. (2000) · Structure · doi:10.1016/s0969-2126(00)00516-5 · Cited by 168 · cited 1×
“Tyrosine 897 is a phosphorylation site and negatively regulates TIE2 activation by preventing dimerization of the kinase domains or by recruiting phosphatases 15.”
Gault, J., Shenkar, R., Recksiek, P., & Awad, I. A. (2005) · Stroke · doi:10.1161/01.str.0000157586.20479.fd · Cited by 157 · cited 1×
“Evidence for local mutations have also been reported in one patient with GVM, and patients with cerebral cavernous malformations: both dominant, multifocal, Mendelian disorders 4,22-24.”
Allelic and locus heterogeneity in inherited venous malformations
Calvert, J. T., Riney, T. J., Kontos, C. D., Cha, E. H., Prieto, V. G., Shea, C. R., Berg, J. N., Nevin, N. C., Simpson, S. A., Pasyk, K. A., et al. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.7.1279 · Cited by 143
Self-citationFrom germline towards somatic mutations in the pathophysiology of vascular anomalies
Limaye, N., Boon, L. M., & Vikkula, M. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp002 · Cited by 137 · cited 1×
“Venous malformation (VM) is the most frequent malformation referred to specialized vascular anomaly centers 1-3.”
Self-citationDeletion of the Carboxyl Terminus of Tie2 Enhances Kinase Activity, Signaling, and Function
Niu, X.-L., Peters, K. G., & Kontos, C. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203995200 · Cited by 71 · cited 1×
“The carboxy-terminal tail of TIE2 functions as an inhibitory loop 18 and it is possible that K1100N causes a conformational change, releasing this inhibitory effect, as evidenced by increased phosphorylation in our study.”
Taylor, G. R., Reedijk, M., Rothwell, V. M., Rohrschneider, L. R., & Pawson, T. J. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03611.x · Cited by 62 · cited 1×
“It may be essential for protein-protein interactions and signal transduction via autophosphorylation of KID-located tyrosines 16,17.”
Heidaran, M. A., Pierce, J. H., Lombardi, D. P., Ruggiero, M., Gutkind, J. S., Matsui, T., & Aaronson, S. A. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.1.134-142.1991 · Cited by 48
Cited by
Therapeutic targeting of the angiopoietin–TIE pathway
Saharinen, P., Eklund, L., & Alitalo, K. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.278 · Cited by 620
Limaye, N., Wouters, V., Uebelhoer, M., Tuominen, M., Wirkkala, R., Mulliken, J. B., Eklund, L., Boon, L. M., & Vikkula, M. (2009) · Nature Genetics · doi:10.1038/ng.272 · Cited by 492
Self-citationSomatic Activating PIK3CA Mutations Cause Venous Malformation
Limaye, N., Kangas, J., Mendola, A., Godfraind, C., Schlögel, M. J., Helaers, R., Eklund, L., Boon, L. M., & Vikkula, M. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.11.011 · Cited by 351
Self-citationAngiopoietin receptor TEK mutations underlie primary congenital glaucoma with variable expressivity
Souma, T., Tompson, S. W., Thomson, B. R., Siggs, O. M., Kizhatil, K., Yamaguchi, S., Feng, L., Limviphuvadh, V., Whisenhunt, K. N., Maurer-Stroh, S., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85830 · Cited by 259
Somatic PIK3CA mutations as a driver of sporadic venous malformations
Castel, P., Carmona, F. J., Grego-Bessa, J., Berger, M. F., Viale, A., Anderson, K. V., Bague, S., Scaltriti, M., Antonescu, C. R., Baselga, E., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf1164 · Cited by 216
Self-citation
Metadata
- Authors
- Wouters, V., Limaye, N., Uebelhoer, M., Irrthum, A., Boon, L. M., Mulliken, J. B., Enjolras, O., Baselga, E., Berg, J., Dompmartin, A., Ivarsson, S. A., Kangesu, L., Lacassie, Y., Murphy, J., Teebi, A. S., Penington, A., Rieu, P., & Vikkula, M.
- Venue
- European Journal of Human Genetics
- Published
- 2009-11-04
- Volume
- 18
- Issue
- 4
- Pages
- 414-420
- ISSN
- 1018-4813 (ISSN-L)
- 1476-5438
- OpenAlex
- W2043280755
- Cited by
- 195
- References
- 18
- FWCI
- 7.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.